Evidence map›Paper›PMID 37761328›Full record

ArticleDiagnostics (Basel, Switzerland)2023

A Key Role of CD8+ T Cells in Controlling of Tuberculosis Infection.

Igor Kudryavtsev, Yulia Zinchenko, Maria Serebriakova, Tatiana Akisheva, Artem Rubinstein, Andrei Savchenko, Alexandr Borisov, Vasilij Belenjuk, Anna Malkova, Piotr Yablonskiy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Host- and pathogen-related determinants of pulmonaryEuropean respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Recombinant BCG vaccine expressing multistage antigens ofHuman vaccines & immunotherapeutics · 2024
    Article
  8. Memory stem CD8Frontiers in cellular and infection microbiology · 2024
    Review
  9. Characterizing the immune response toFrontiers in immunology · 2024
    Review
  10. Review
  11. ImmunoTargets and therapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Igor KudryavtsevInstitution of Experimental Medicine, Department of Immunology, 197376 St-Petersburg, Russia.
Yulia ZinchenkoResearch Institute of Phthisiopulmonology, 191036 St-Petersburg, Russia.ORCID 0000-0002-6273-4304
Maria SerebriakovaInstitution of Experimental Medicine, Department of Immunology, 197376 St-Petersburg, Russia.
Tatiana AkishevaInstitution of Experimental Medicine, Department of Immunology, 197376 St-Petersburg, Russia.
Artem RubinsteinInstitution of Experimental Medicine, Department of Immunology, 197376 St-Petersburg, Russia.ORCID 0000-0002-8493-5211
Andrei SavchenkoFederal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660022 Krasnoyarsk, Russia.ORCID 0000-0001-5829-672X
Alexandr BorisovFederal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660022 Krasnoyarsk, Russia.ORCID 0000-0002-9026-2615
Vasilij BelenjukFederal Research Center «Krasnoyarsk Science Center» of the Siberian Branch of the Russian Academy of Sciences, Scientific Research Institute of Medical Problems of the North, 660022 Krasnoyarsk, Russia.ORCID 0000-0003-2848-0846
Anna MalkovaDepartment of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel 40700, Israel.ORCID 0000-0002-6008-1354
Piotr YablonskiyResearch Institute of Phthisiopulmonology, 191036 St-Petersburg, Russia.
Dmitry KudlayDepartment of Pharmacology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia.ORCID 0000-0003-1878-4467
Anna StarshinovaAlmazov National Medical Research Centre, 197341 St-Petersburg, Russia.
Institute of Experimental Medicine · RUResearch Institute of Medical Problems of the North · RUFederal Almazov North-West Medical Research Centre · RUSaint-Petersburg Research Institute of Phthisiopulmonology · RUAriel University · ILSechenov University · RU

Funding

Federal Almazov North-West Medical Research Centre . 075-15-2022-301
6 · The paper itself

Abstract

The main role in the control of tuberculosis infection is played by macrophages and Th1 and CD8+ T cells. The study aimed to identify the most diagnostically significant CD8+ T cell subsets in tuberculosis patients.

methodsPeripheral blood samples from patients with clinical, radiological, and bacteriologically confirmed pulmonary tuberculosis (TB, n = 32) and healthy subjects (HC, n = 31) were collected and analyzed using 10-color flow cytometry.

resultsThe frequency of the EM4 CD3+CD8+ cells was reduced in the peripheral blood of patients with pulmonary tuberculosis, while the relative and absolute number of EM1 CD3+CD8+ cells increased compared to the control group. CD57 expression was reduced in patients with pulmonary tuberculosis on EM1, EM2, and pE1 CD3+CD8+ cells, whereas the EM3 cells had a high level of CD57 expression. The relative and absolute number of Tc2 (CCR6-CXCR3-) cells in peripheral blood in patients with pulmonary tuberculosis was increased, while the frequency of Tc1 (CCR6-CXCR3+) was decreased, compared to healthy donors.

conclusionsPatients with pulmonary tuberculosis have an abnormal CD3+CD8+ cell profile and demonstrate their impaired maturation and functional activity.

Indexed as

CD3+CD8+chemokine receptorsmemory CD8+ T cellsTc1Tc17Tc2tuberculosis

Identifiers

PMID37761328
PMCPMC10528134
OpenAlexW4386838351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.